Maynard Um
-
-
-
-
-
-
-
TG Therapeutics presents BRIUMVI data at multiple sclerosis forum
-
-
-
-
-
-
-
TG Therapeutics reports six-year BRIUMVI data at ECTRIMS conference
-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on TG Therapeutics (TGTX)
-
-
-
-
-
-
-
Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones
-
-
-
-
-
-
-
Zurn Elkay Water, Clear Secure, TG Therapeutics, others to join S&P SmallCap 600
-
-
404,875 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

